Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinoma.

Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinoma.

Item
http://www.wikidata.org/entity/Q36370054
EGFR C797S mutation mediates resistance to third-generation inhibitors in T790M-positive non-small cell lung cancerThird-generation inhibitors targeting EGFR T790M mutation in advanced non-small cell lung cancerKirsten Ras* oncogene: Significance of its discovery in human cancer researchClinical applications of PD-L1 bioassays for cancer immunotherapy.Pembrolizumab in the treatment of metastatic non-small-cell lung cancer: patient selection and perspectives.The next generation of immunotherapy: keeping lung cancer in check.Mechanisms of resistance to third-generation EGFR tyrosine kinase inhibitors.KRAS mutation-induced upregulation of PD-L1 mediates immune escape in human lung adenocarcinoma.Immune biomarkers of treatment failure for a patient on a phase I clinical trial of pembrolizumab plus radiotherapy.Effectiveness and safety of PD-1/PD-L1 inhibitors in the treatment of solid tumors: a systematic review and meta-analysis.Clinical trials of CAR-T cells in ChinaCD274 (PDL1) and JAK2 genomic amplifications in pulmonary squamous-cell and adenocarcinoma patients.Efficacy of pemetrexed-based regimens in advanced non-small cell lung cancer patients with activating epidermal growth factor receptor mutations after tyrosine kinase inhibitor failure: a systematic review.[Research Progress of KRAS Mutation in Non-small Cell Lung Cancer].
P2860

Near complete response after single dose of nivolumab in patient with advanced heavily pre-treated KRAS mutant pulmonary adenocarcinoma.

Item
http://www.wikidata.org/entity/Q36370054
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Near complete response after s ...... tant pulmonary adenocarcinoma.
@ast
Near complete response after s ...... tant pulmonary adenocarcinoma.
@en
type
label
Near complete response after s ...... tant pulmonary adenocarcinoma.
@ast
Near complete response after s ...... tant pulmonary adenocarcinoma.
@en
prefLabel
Near complete response after s ...... tant pulmonary adenocarcinoma.
@ast
Near complete response after s ...... tant pulmonary adenocarcinoma.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932
P356
P1433
P1476
Near complete response after s ...... tant pulmonary adenocarcinoma.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P5875
P6179
P698
P921
P932